Since CD47 is expressed by all cells throughout the body, and SIRPα is only expressed on the neuronal cells and myeloid cells,[36] developing novel strategies to against SIRPα holds much more superiority to enhance tumor‐phagocytosis of macrophages and reduce side effects. The gene discussed is SIRPA; the disease is neoplasm.